Abstract
Background Despite thousands of influenza cases annually recorded by surveillance systems around the globe, estimating the transmission patterns of seasonal influenza is challenging.
Methods We develop an age-structured mathematical model to influenza transmission to analyze ten consecutive seasons (from 2010-2011 to 2019-2020) of influenza epidemiological and virological data reported to the Italian surveillance system.
Results We estimate that 18.4%-29.3% of influenza infections are detected by the surveillance system. Influenza infection attack rate varied between 18.0% and 35.6% and is generally larger for seasons characterized by the circulation of A/H3N2 and/or B types/subtypes. Individuals aged 14 years or less are the most affected age-segment of the population, with A viruses especially affecting children aged 0-4 years. For all influenza types/subtypes, the mean effective reproduction number is estimated to be generally in the range 1.1-1.4 (8 out of 10 seasons) and never exceeding 1.55. The age-specific susceptibility to infection appears to be a type/subtype-specific feature.
Conclusions The results presented in this study provide insights on type/subtype-specific transmission patterns of seasonal influenza that could be instrumental to fine-tune immunization strategies and non-pharmaceutical interventions aimed at limiting seasonal influenza spread and burden.
Competing Interest Statement
MA has received consultancy fees from Seqirus. All other authors declare no competing interests
Funding Statement
F.T. and S.M. acknowledge funding from the European Commission H2020 project MOOD and from the VRT Foundation Trento project Epidemiologia e transmissione di COVID-19 in Trentino. The present study received an unconditional funding from Seqirus. Seqirus had a possibility to review the study protocol but had no role in any other aspect of the study conduct. In particular, Seqirus had no role in the design and conduct of the study, the collection, management, analysis, and interpretation of the data, or the preparation, or approval of the manuscript, and decision to submit for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not applicable
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵$ Joint senior authors
Data Availability
The datasets analysed during the current study are available from the corresponding author on reasonable request.
LIST OF ABBREVIATIONS
- ILI
- Influenza-like illness
- GP
- General practitioner
- PD
- Pediatrician
- CRF
- Case report form
- NIC
- National influenza center
- AR
- Attack rate
- MCMC
- Markov Chain Monte Carlo
- NGM
- Next Generation Matrix
- Re
- Effective reproduction number
